Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angeliq in Postmenopausal Thai Women with Vasomotor Symptoms
NCT00185328Phase 4Completed
- Sponsor
- Bayer
- Start
- Sep 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of estradiol + drospirenone in vasomotor symptoms, sponsored by Bayer. Started Sep 2005; status: completed.
02
Drugs
estradiol + drospirenone
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT00185328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185328.